Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Plenary Session 4: Advances in Targeted Therapy

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
Targeting driving genomic mutations in breast cancer
José Baselga
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from 2015 Molecular Targets and Cancer Therapeutics conference on November 8, 2015 8:00 AM-10:00 AM
Title to be announced
Jeffrey A. Engelman
Massachusetts General Hospital, Boston, MA, United States
from 2015 Molecular Targets and Cancer Therapeutics conference on November 8, 2015 8:00 AM-10:00 AM
Basket studies: Lessons learned and future directions
David Hyman
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from 2015 Molecular Targets and Cancer Therapeutics conference on November 8, 2015 8:00 AM-10:00 AM
Dissecting colorectal cancer in multiple targetable subtypes
Josep Tabernero
Vall d'Hebron University Hospital, Barcelona, Spain
from 2015 Molecular Targets and Cancer Therapeutics conference on November 8, 2015 8:00 AM-10:00 AM
The first reported results of AG-120, a first-in-class, potent inhibitor of the IDH1 mutant protein, in a Phase I study of patients with advanced IDH1-mutant solid tumors, including gliomas
Howard Burris
Sarah Cannon Research Institute, Nashville, TN, United States
from 2015 Molecular Targets and Cancer Therapeutics conference on November 8, 2015 8:00 AM-10:00 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5